Verdence Capital Advisors’s Medpace MEDP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-1,049
Closed -$329K 726
2025
Q2
$329K Buy
1,049
+57
+6% +$17.1K 0.02% 530
2025
Q1
$302K Buy
992
+85
+9% +$28.6K 0.02% 524
2024
Q4
$301K Buy
907
+10
+1% +$3.39K 0.02% 510
2024
Q3
$299K Buy
+897
New +$341K 0.02% 521

Other funds holding MEDP

Verdence Capital Advisors's MEDP Position: Q3 2025 in Review

Verdence Capital Advisors sold out of Medpace (MEDP) in Q3 2025, closing a stake of 1,049 shares — an estimated $329K sold.

Verdence Capital Advisors first reported a position in MEDP in Q3 2024 and held it in 4 quarters. The position peaked at $329K in Q2 2025. 672 funds tracked by Wall St. Rank hold MEDP as of Q3 2025.

  • Verdence Capital Advisors reported no remaining Medpace position as of Q3 2025 after selling out during the quarter.
  • Verdence Capital Advisors sold 1,049 Medpace shares in Q3 2025, an estimated $329K.
  • Verdence Capital Advisors first reported a position in Medpace in Q3 2024 and held it in 4 quarters.
  • Verdence Capital Advisors's Medpace position peaked at $329K in Q2 2025.
  • 672 funds tracked by Wall St. Rank held Medpace as of Q3 2025.

Based on Verdence Capital Advisors's 13F filing for Q3 2025, filed 29 Oct 2025.